Implantica completes first RefluxStop procedures in the US

Implantica announced the successful completion of the first commercial RefluxStop procedures in the United States, which took place on November 4, 2026, at the University of Southern California in Los Angeles. RefluxStop is an implantable device designed to treat gastroesophageal reflux disease.

Detected & updated continuously · Source: Nebula